PRNP and ocular melanoma: Prospective longitudinal studies will enable to evaluate whether detection of PrPSc in OM collected from subjects of a well characterized Italian FFI family, which is currently involved in a preventive clinical trial with doxycycline, might be used as quantifiable biomarker to monitor the effect of the drug on PrP replication and disease progression33.